299 related articles for article (PubMed ID: 1425426)
1. Suramin inhibits bone resorption and reduces osteoblast number in a neonatal mouse calvarial bone resorption assay.
Walther MM; Kragel PJ; Trahan E; Venzon D; Blair HC; Schlesinger PH; Jamai-Dow C; Ewing MW; Myers CE; Linehan WM
Endocrinology; 1992 Nov; 131(5):2263-70. PubMed ID: 1425426
[TBL] [Abstract][Full Text] [Related]
2. Cystatin C, and inhibitor of bone resorption produced by osteoblasts.
Lerner UH; Johansson L; Ranjsö M; Rosenquist JB; Reinholt FP; Grubb A
Acta Physiol Scand; 1997 Sep; 161(1):81-92. PubMed ID: 9381954
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1 stimulates release of insulin-like growth factor-I from neonatal mouse calvaria by a prostaglandin synthesis-dependent mechanism.
Linkhart TA; MacCharles DC
Endocrinology; 1992 Nov; 131(5):2297-305. PubMed ID: 1425428
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of insulin-like growth factor-I (IGF-I) and IGF-II release from cultured neonatal mouse calvaria by parathyroid hormone, transforming growth factor-beta, and 1,25-dihydroxyvitamin D3.
Linkhart TA; Keffer MJ
Endocrinology; 1991 Mar; 128(3):1511-8. PubMed ID: 1999170
[TBL] [Abstract][Full Text] [Related]
5. Suramin suppresses hypercalcemia and osteoclastic bone resorption in nude mice bearing a human squamous cancer.
Yoneda T; Williams P; Rhine C; Boyce BF; Dunstan C; Mundy GR
Cancer Res; 1995 May; 55(9):1989-93. PubMed ID: 7728770
[TBL] [Abstract][Full Text] [Related]
6. Suramin is a potent inhibitor of calcemic hormone- and growth factor-induced bone resorption in vitro.
Farsoudi KH; Pietschmann P; Cross HS; Peterlik M
J Pharmacol Exp Ther; 1993 Feb; 264(2):579-83. PubMed ID: 8382276
[TBL] [Abstract][Full Text] [Related]
7. Functional characterization of osteoblasts and osteoclasts from alkaline phosphatase knockout mice.
Wennberg C; Hessle L; Lundberg P; Mauro S; Narisawa S; Lerner UH; Millán JL
J Bone Miner Res; 2000 Oct; 15(10):1879-88. PubMed ID: 11028439
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta stimulates bone resorption in neonatal mouse calvariae by a prostaglandin-unrelated but cell proliferation-dependent pathway.
Lerner UH
J Bone Miner Res; 1996 Nov; 11(11):1628-39. PubMed ID: 8915770
[TBL] [Abstract][Full Text] [Related]
9. The anti-bone-resorptive agent calcitonin also acts in vitro to directly increase bone formation and bone cell proliferation.
Farley JR; Tarbaux NM; Hall SL; Linkhart TA; Baylink DJ
Endocrinology; 1988 Jul; 123(1):159-67. PubMed ID: 3383771
[TBL] [Abstract][Full Text] [Related]
10. IL-6 is produced by osteoblasts and induces bone resorption.
Ishimi Y; Miyaura C; Jin CH; Akatsu T; Abe E; Nakamura Y; Yamaguchi A; Yoshiki S; Matsuda T; Hirano T
J Immunol; 1990 Nov; 145(10):3297-303. PubMed ID: 2121824
[TBL] [Abstract][Full Text] [Related]
11. Effects of electromagnetic stimulation on the functional responsiveness of isolated rat osteoclasts.
Shankar VS; Simon BJ; Bax CM; Pazianas M; Moonga BS; Adebanjo OA; Zaidi M
J Cell Physiol; 1998 Sep; 176(3):537-44. PubMed ID: 9699506
[TBL] [Abstract][Full Text] [Related]
12. Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption.
Löwik CW; Nibbering PH; van de Ruit M; Papapoulos SE
J Clin Invest; 1994 Apr; 93(4):1465-72. PubMed ID: 8163651
[TBL] [Abstract][Full Text] [Related]
13. A novel synthetic triazolotriazepine derivative JTT-606 inhibits bone resorption by down-regulation of action and production of bone resorptive factors.
Chikazu D; Shindo M; Iwasaka T; Katagiri M; Manabe N; Takato T; Nakamura K; Kawaguchi H
J Bone Miner Res; 2000 Apr; 15(4):674-82. PubMed ID: 10780859
[TBL] [Abstract][Full Text] [Related]
14. Human parathyroid hormone-related peptide-(107-111) does not inhibit bone resorption in neonatal mouse calvariae.
Sone T; Kohno H; Kikuchi H; Ikeda T; Kasai R; Kikuchi Y; Takeuchi R; Konishi J; Shigeno C
Endocrinology; 1992 Dec; 131(6):2742-6. PubMed ID: 1306984
[TBL] [Abstract][Full Text] [Related]
15. Osteoblastic control of osteoclast bone resorption in a serum-free co-culture system. Lack of effect of parathyroid hormone.
Teti A; Grano M; Colucci S; Zambonin Zallone A
J Endocrinol Invest; 1992; 15(9 Suppl 6):63-8. PubMed ID: 1300341
[No Abstract] [Full Text] [Related]
16. On the role of cyclic AMP as a mediator of bone resorption: gamma-interferon completely inhibits cholera toxin- and forskolin-induced but only partially inhibits parathyroid hormone-stimulated 45Ca release from mouse calvarial bones.
Lerner UH; Ransjö M; Ljunggren O; Klaushofer K; Hoffmann O; Peterlik M
J Bone Miner Res; 1991 Jun; 6(6):551-60. PubMed ID: 1653515
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid hormone (1-34) and Nleu8,18Tyr34-parathyroid hormone, (3-34) amide increase diacylglycerol in neonatal mouse calvaria.
Stewart PJ; Stathopoulos VM; Stern PH
Horm Metab Res; 1991 Nov; 23(11):535-8. PubMed ID: 1816064
[TBL] [Abstract][Full Text] [Related]
18. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.
Hill PA; Reynolds JJ; Meikle MC
Endocrinology; 1995 Jan; 136(1):124-31. PubMed ID: 7828521
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1 and tumor necrosis factor-alpha induce collagenolysis and bone resorption by regulation of matrix metalloproteinase-2 in mouse calvarial bone cells.
Kang BS; Park YG; Cho JY; Kim JK; Lee TK; Kim DW; Gu YH; Suzuki I; Chang YC; Kim CH
Immunopharmacol Immunotoxicol; 2003 Aug; 25(3):347-64. PubMed ID: 19180798
[TBL] [Abstract][Full Text] [Related]
20. Effects of parathyroid hormone and calcitonin on osteoclast formation in vitro.
Feldman RS; Krieger NS; Tashjian AH
Endocrinology; 1980 Oct; 107(4):1137-43. PubMed ID: 7408763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
